We recently reported that mice that showed tumor regression with anti-CCR8 therapy rejected re-inoculated tumors because of the formation of memory T cells, whereas mice in which tumors were surgically removed failed to form memory T cells and thus showed tumor regrowth19. Here, CCR8 is linked to neoplasm.